Results 31 to 40 of about 140 (69)

Larger End-Diastolic Volume Associates With Response to Cell Therapy in Patients With Nonischemic Dilated Cardiomyopathy. [PDF]

open access: yesMayo Clin Proc, 2020
Frljak S   +6 more
europepmc   +1 more source

Effectiveness of Stem Cell Therapies in Improving Clinical Outcomes in Patients With Heart Failure. [PDF]

open access: yesCureus, 2021
Bhawnani N   +6 more
europepmc   +1 more source

Cardiopoietic cell therapy for advanced ischaemic heart failure : results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial

open access: yes
Altres ajuts: This work was supported by Celyad, SA (Mont-Saint-Guibert, Belgium). Celyad has received research grants from the Walloon Region (Belgium, DG06 funding).Cardiopoietic cells, produced through cardiogenic conditioning of patients' mesenchymal
Sanz-Ruiz, Ricardo   +54 more
core  

Decoded cardiopoietic cell secretome linkage to heart repair biosignature. [PDF]

open access: yesStem Cells Transl Med
Garmany A   +6 more
europepmc   +1 more source

Biomaterial-Assisted Stem Cell Therapy and Exosome Delivery in Myocardial Infarction: A Narrative Review. [PDF]

open access: yesBiomimetics (Basel)
Răduţă AI   +5 more
europepmc   +1 more source

PSME4 Degrades Acetylated YAP1 in the Nucleus of Mesenchymal Stem Cells. [PDF]

open access: yesPharmaceutics, 2022
Kim YS   +10 more
europepmc   +1 more source

Posology for Regenerative Therapy. [PDF]

open access: yesCirc Res, 2017
Terzic A, Behfar A.
europepmc   +1 more source

Home - About - Disclaimer - Privacy